Best Practices to Individualize and Optimize Diabetes Management With Integrated Continuous Glucose Monitoring Devices

This activity includes patient counseling videos.

Program Description

Recent technological advances in diabetes management have improved perceptions of integrated continuous glucose monitoring (iCGM) devices. However, provider barriers to the utilization of iCGM devices still exist. This webinar will examine how health care professionals can optimize diabetes management by using a standardized approach to review and interpret ambulatory glucose profile (AGP) reports effectively and efficiently. This activity will also include patient counseling videos to illustrate motivational interviewing techniques when reviewing and interpreting an AGP report with a patient to encourage lifestyle modifications and recommend changes to therapy to achieve glycemic targets.

Target audience: Retail pharmacists and pharmacy technicians

Type of activity: Application for pharmacists; Knowledge for pharmacy technicians
Release date: March 16, 2023
Expiration date: May 16, 2023

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, pharmacists will be able to:

• Illustrate approaches pharmacists can employ to maximize use of integrated continuous glucose monitoring (iCGM) data 
• Optimize the role of the pharmacist in improving the management of diabetes through implementation of iCGM for persons with diabetes

At the completion of this activity, pharmacy technicians will be able to:

• Cite health care professional barriers to integrated continuous glucose monitoring (iCGM) devices 
• State how pharmacy technicians can assist pharmacists implementing iCGM for persons with diabetes

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity numbers 0290-0000-23-014-L01-P and 0290-0000-23-015-L01-T. The activity is available for CE credit through May 16, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Sara (Mandy) Reece, PharmD, CDCES, BC-ADM, BCACP, FADCES, has the following financial relationships with commercial interests to disclose:
Consultant: Sanofi, Novo Nordisk

Speakers Bureau: Novo Nordisk

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms